WebApr 7, 2024 · The 26.30% of Shuttle Pharmaceuticals Holdings Inc.’s shares are in the hands of company insiders while institutional holders own 3.70% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.18 million on Mar 14, 2024, giving us a short ratio of 1.72. WebFeb 23, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the …
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price, News, …
WebSep 20, 2024 · Shuttle Pharmaceuticals Anatoly Dritschilo, M.D., CEO 240-403-4212 [email protected]. Investor Contacts Lytham Partners, LLC Robert Blum, Joe Dorame, Joe Diaz 602-889-9700 Web2 days ago · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of … reaction of benzaldehyde with acetophenone
Shuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate …
WebMar 15, 2024 · SHPH Shuttle Pharmaceuticals Holdings Inc Annual Report (10-k) FORWARD LOOKING STATEMENTS . This Annual Report on Form 10-K (including the section … WebAug-30-22 04:40PM. Shuttle Pharmaceuticals Announces Pricing of Initial Public Offering. PR Newswire. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle … WebDec 31, 2024 · Shuttle Pharmaceuticals Anatoly Dritschilo, M.D., CEO 240-403-4212 [email protected] Investor Contacts Lytham Partners, LLC Robert Blum 602-889-9700 [email protected] SOURCE Shuttle ... how to stop being shy around your boyfriend